Nanhua Bio (China) Today
| 000504 Stock | 10.19 0.36 3.41% |
Performance15 of 100
| Odds Of DistressLess than 19
|
Nanhua Bio is trading at 10.19 as of the 16th of December 2024, a 3.41 percent decrease since the beginning of the trading day. The stock's open price was 10.55. Nanhua Bio has less than a 19 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. The performance scores are derived for the period starting the 16th of November 2024 and ending today, the 16th of December 2024. Click here to learn more.
Business Domain Media & Entertainment | IPO Date 28th of October 1991 | Category Healthcare | Classification Communication Services |
Nanhua Bio is entity of China. It is traded as Stock on SHE exchange. The company has 330.02 M outstanding shares. More on Nanhua Bio Medicine
Moving together with Nanhua Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Nanhua Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Nanhua Bio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Nanhua Bio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Publishing, Media & Entertainment, Communication Services, Communication Services, Media, Media & Entertainment, Communication Services (View all Sectors) | ||||
Nanhua Bio's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Nanhua Bio's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsNanhua Bio can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Nanhua Bio's financial leverage. It provides some insight into what part of Nanhua Bio's total assets is financed by creditors.
| |||||
Nanhua Bio Medicine (000504) is traded on Shenzhen Stock Exchange in China and employs 5 people. Nanhua Bio is listed under Publishing category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.36 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nanhua Bio's market, we take the total number of its shares issued and multiply it by Nanhua Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Nanhua Bio Medicine operates under Media sector and is part of Communication Services industry. The entity has 330.02 M outstanding shares.
Nanhua Bio generates positive cash flow from operations, but has no cash available
Check Nanhua Bio Probability Of Bankruptcy
Ownership AllocationNanhua Bio Medicine maintains a total of 330.02 Million outstanding shares. 30% of Nanhua Bio outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Nanhua Ownership Details
Nanhua Bio Medicine Risk Profiles
Although Nanhua Bio's alpha and beta are two of the key measurements used to evaluate Nanhua Bio's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.94 | |||
| Semi Deviation | 3.03 | |||
| Standard Deviation | 3.8 | |||
| Variance | 14.45 |
Nanhua Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Nanhua Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Nanhua Bio Corporate Executives
Elected by the shareholders, the Nanhua Bio's board of directors comprises two types of representatives: Nanhua Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nanhua. The board's role is to monitor Nanhua Bio's management team and ensure that shareholders' interests are well served. Nanhua Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nanhua Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pengbin Lin | Deputy CFO | Profile |
Other Information on Investing in Nanhua Stock
Nanhua Bio financial ratios help investors to determine whether Nanhua Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanhua with respect to the benefits of owning Nanhua Bio security.